相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Flow Rate of Cerebrospinal Fluid Through a Spinal Needle Can Accurately Predict Intracranial Pressure in Cryptococcal Meningitis
Tom H. Boyles et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii
Shawn R. Lockhart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Global access to antifungal therapy and its variable cost
Matthew Kneale et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study
Joshua Rhein et al.
LANCET INFECTIOUS DISEASES (2016)
Funding and Innovation in Diseases of Neglected Populations: The Paradox of Cryptococcal Meningitis
Marcio L. Rodrigues
PLOS NEGLECTED TROPICAL DISEASES (2016)
Toward improved anti-cryptococcal drugs: Novel molecules and repurposed drugs
Damian J. Krysan
FUNGAL GENETICS AND BIOLOGY (2015)
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial
Sayoki Mfinanga et al.
LANCET (2015)
High Treatment Retention Rate in HIV-Infected Patients Receiving Antiretroviral Therapy at Two Large HIV Clinics in Hanoi, Vietnam
Shoko Matsumoto et al.
PLOS ONE (2015)
Advanced HIV Disease at Entry into HIV Care and Initiation of Antiretroviral Therapy During 2006-2011: Findings From Four Sub-Saharan African Countries
Maria Lahuerta et al.
CLINICAL INFECTIOUS DISEASES (2014)
Bacterial Meningitis in Malawian Adults, Adolescents, and Children During the Era of Antiretroviral Scale-up and Haemophilus influenzae Type b Vaccination, 2000-2012
Emma C. Wall et al.
CLINICAL INFECTIOUS DISEASES (2014)
The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis
Melissa A. Rolfes et al.
CLINICAL INFECTIOUS DISEASES (2014)
Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study
Renee Donahue Carlson et al.
METABOLIC BRAIN DISEASE (2014)
Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal
Angela Loyse et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
Angela Loyse et al.
LANCET INFECTIOUS DISEASES (2013)
Combination Antifungal Therapy for Cryptococcal Meningitis
Jeremy N. Day et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis following Treatment Induction with 800 mg Oral Fluconazole in Blantyre, Malawi
Camilla Rothe et al.
PLOS ONE (2013)
Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa
Joseph N. Jarvis et al.
PLOS ONE (2013)
T-2307 Causes Collapse of Mitochondrial Membrane Potential in Yeast
Tatsuya Shibata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Neglected Fungal Diseases in Sub-Saharan Africa: A Call to Action
Nelesh P. Govender et al.
CURRENT FUNGAL INFECTION REPORTS (2011)
Combination Flucytosine and High-Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi
Jesse C. Nussbaum et al.
CLINICAL INFECTIOUS DISEASES (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Outcomes of cryptococcal meningitis in antiretroviral naive and experienced patients in South Africa
Joseph N. Jarvis et al.
JOURNAL OF INFECTION (2010)
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
Joseph N. Jarvis et al.
AIDS (2009)
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
Benjamin J. Park et al.
AIDS (2009)
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
Stephen D. Lawn et al.
AIDS (2008)
Antiretroviral therapy and early morality in South Africa
Andrew Boulle et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Dose Response Effect of High-Dose Fluconazole for HIV-Associated Cryptococcal Meningitis in Southwestern Uganda
Nicky Longley et al.
CLINICAL INFECTIOUS DISEASES (2008)
Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: The role of fluconazole resistance and immune reconstitution
Tihana Bicanic et al.
CLINICAL INFECTIOUS DISEASES (2006)
Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole
C. F. Schaars et al.
BMC INFECTIOUS DISEASES (2006)
Epidemiology of HIV-associated cryptococcosis in France (1985-2001):: comparison of the pre- and post-HAART eras
F Dromer et al.
AIDS (2004)
The changing epidemiology of cryptococcosis: An update from population-based active surveillance in 2 large metropolitan areas, 1992-2000
SA Mirza et al.
CLINICAL INFECTIOUS DISEASES (2003)
分享论文
